*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Artemether suspension is a <strong>parenteral-grade antimalarial formulation</strong> derived from artemisinin. It utilizes advanced <strong>microemulsion technology</strong> to ensure stability and bioavailability. The active ingredient corresponds to the molecular formula <strong>C16H26O5</strong> (CAS No. 71967-40-5).</p>
<h3>Application</h3>
<ul>
<li><strong>Tropical Medicine:</strong> Treatment of severe malaria in pediatric populations unable to swallow tablets.</li>
<li><strong>Hospital Logistics:</strong> Emergency protocols for rapid parasite clearance in endemic regions.</li>
<li><strong>R&D:</strong> Clinical trials evaluating fixed-dose combination therapies with lumefantrine.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated for intramuscular injection due to solubility risks. Store below <strong>25°C</strong> protected from light. Avoid use during the first trimester of pregnancy unless benefits outweigh risks.</p>